Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04247672
Other study ID # 2019.0084
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 3, 2020
Est. completion date January 22, 2036

Study information

Verified date April 2022
Source Spaarne Gasthuis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.


Description:

Every year, 1.5 million total knee arthroplasties (TKA) are performed worldwide in patients whose joints have been severely affected by osteoarthritis, rheumatoid arthritis, or trauma, causing intense pain and loss of function. Due to the ageing society, these numbers are expected to have increased six-fold to 3.48 million cases annually by 2030. Even though joint replacement provides satisfactory and durable results for most patients, 20% is thought to still not be satisfied with their artificial joint. To accommodate this dissatisfied population and improve durability of implants even more, several knee systems have been developed over the years. One of the newest models is the ATTUNE knee system (DePuy, Warsaw, Indiana, USA). One of the landmark features is a gradually reducing radius in the geometry of the femoral component, more closely mimicking the anatomical patellofemoral joint and facilitating more natural femoral rollback during flexion. Comparisons of the cemented ATTUNE with previous knee systems show promising results in terms of patellofemoral outcomes, but fail to demonstrate definitive superiority in terms of all patient reported outcomes. Clinical superiority of the ATTUNE tends to abate with longer follow-up, implicating a possible superiority in the short-term recovery and return to activities. There is no follow-up study reporting the results of the uncemented ATTUNE. Moreover, all previously cited studies report better patellofemoral outcomes with patellar resurfacing, making it still unclear whether the implicated superior design changes of the femoral component hold ground without patellar resurfacing. The primary objective is to report survivorship, complications and patient reported outcome measures associated with the uncemented ATTUNE rotating platform knee system. Secondary objectives are (1) evaluate patient reported (patellofemoral) outcomes (2) assess return to work and sport after TKA (3) translate and validate the Dutch version of the University of California, Los Angeles (UCLA) activity scale and (4) analyse psychologic factors (such as pain catastrophising and coping) and the impact on dissatisfaction following TKA.


Recruitment information / eligibility

Status Recruiting
Enrollment 900
Est. completion date January 22, 2036
Est. primary completion date January 22, 2024
Accepts healthy volunteers
Gender All
Age group 21 Years to 90 Years
Eligibility Inclusion Criteria: - End-stage osteoarthritis of the knee warranting joint replacement therapy. - Indicated for an ATTUNE total knee system as part of regular clinical practice. - Capability and willingness to sign informed consent and comply with follow-up procedures. - Capable enough in Dutch or English to be able to understand study procedures Exclusion Criteria: - Unable or unwilling to sign informed consent and comply with follow-up - Indication for primary revision arthroplasty - Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)

Study Design


Intervention

Device:
Total Knee Arthroplasty (uncemented rotating platform ATTUNE)
All patients receive an uncemented ATTUNE rotating platform knee system.

Locations

Country Name City State
Netherlands Spaarne Gasthuis Hoofddorp Noord-Holland

Sponsors (1)

Lead Sponsor Collaborator
Spaarne Gasthuis

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survivorship Calculated by determining revision rate. Septic, aseptic and all-cause revision rates will be calculated seperately. 10 year
Primary Complication rate All substantial complications associated with total knee arthroplasty will be registered and reported 10 year
Primary Forgotten Joint Score 12 (FJS-12) 10 year
Primary Kujala Anterior Knee Pain Scale (AKPS) 10 year
Primary Knee injury and Osteoarthritis Outcome Scale - Physical Function Short Form KOOS-PS 10 year
Primary Numeric Rating Scale (NRS) NRS on pain and satisfaction 10 year
Primary EuroQol 5 Dimensions, 3 Levels (EQ5D-3L) 10 year
Secondary 30 second chair stand test (30sCST) The amount of times one can stand up and sit down from a chair in 30 seconds 1 year
Secondary 40m Fast paced walk test (40m-FPWT) The amount of seconds one does to walk 40 meters. 1 year
Secondary Stair climb test (SCT) The time one takes to walk a set of stairs up and down. 1 year
Secondary Tegner activity rating scale 1-item questionnaire 1 year
Secondary University of California, Los Angeles (UCLA) activity rating scale 1-item questionnaire 1 year
Secondary Return to work Assessed by a short self-composed questionnaire, which evaluates what kind of work the patients do, when they started after surgery and whether this is the same as their preoperative job 1 year
Secondary Alignment A long-leg radiograph is performed 1 year after surgery to assess mechanical alignment of the prosthesis with consideration of femur and tibia 1 year
Secondary Patient Health Questionnaire (PHQ-2) 2-item questionnaire to screen for major depressive episodes 10 year
Secondary Pain Self Efficacy Questionnaire (PSEQ) Questionnaire to asses pain self efficacy 10 year
Secondary Pain Catastrophizing Scale (PCS) Explores pain catastrophizing and its relation to pain behaviour 10 year
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4